1. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway
- Author
-
Federica Tonon, Maja Cemazar, Urska Kamensek, Cristina Zennaro, Gabriele Pozzato, Sergio Caserta, Flora Ascione, Mario Grassi, Stefano Guido, Cinzia Ferrari, Laura Cansolino, Francesco Trotta, Biljana Grcar Kuzmanov, Giancarlo Forte, Fabiana Martino, Francesca Perrone, Riccardo Bomben, Valter Gattei, Nicola Elvassore, Erminio Murano, Nhung Hai Truong, Michael Olson, Rossella Farra, Gabriele Grassi, Barbara Dapas, Tonon, Federica, Cemazar, Maja, Kamensek, Urska, Zennaro, Cristina, Pozzato, Gabriele, Caserta, Sergio, Ascione, Flora, Grassi, Mario, Guido, Stefano, Ferrari, Cinzia, Cansolino, Laura, Trotta, Francesco, Kuzmanov, Biljana Grcar, Forte, Giancarlo, Martino, Fabiana, Perrone, Francesca, Bomben, Riccardo, Gattei, Valter, Elvassore, Nicola, Murano, Erminio, Truong, Nhung Hai, Olson, Michael, Farra, Rossella, Grassi, Gabriele, Dapas, Barbara, Cemazar, Maja [0000-0002-1418-1928], Kamensek, Urska [0000-0002-0481-4226], Zennaro, Cristina [0000-0003-4755-1064], Caserta, Sergio [0000-0002-4400-0059], Grassi, Mario [0000-0002-3532-3200], Guido, Stefano [0000-0002-9247-6852], Ferrari, Cinzia [0000-0001-8356-7472], Cansolino, Laura [0000-0002-8330-1532], Forte, Giancarlo [0000-0002-1341-1023], Bomben, Riccardo [0000-0002-8746-9404], Olson, Michael [0000-0003-3428-3507], Grassi, Gabriele [0000-0001-9704-6651], Apollo - University of Cambridge Repository, Tonon, F., Cemazar, M., Kamensek, U., Zennaro, C., Pozzato, G., Caserta, S., Ascione, F., Grassi, M., Guido, S., Ferrari, C., Cansolino, L., Trotta, F., Kuzmanov, B. G., Forte, G., Martino, F., Perrone, F., Bomben, R., Gattei, V., Elvassore, N., Murano, E., Truong, N. H., Olson, M., Farra, R., Grassi, G., and Dapas, B.
- Subjects
Cancer Research ,MMP-2 ,Hepatocellular carcinoma ,hepatocellular carcinoma ,5-azacytidine ,cell cycle ,migration ,miR-139-5p ,ROCK2 ,E2F1 ,Cell cycle ,Migration ,MiR-139-5p ,Oncology ,neoplasms - Abstract
Background: For hepatocellular carcinoma (HCC), effective therapeutic approaches are lacking. As aberrant gene methylation is a major contributor to HCC development, demethylating drugs such as 5-azacytidine (5-Aza) have been proposed. As most 5-Aza mechanisms of action are unknown, we investigated its phenotypic/molecular effects. Methods: 5-Aza effects were examined in the human HCC cell lines JHH-6/HuH-7 and in the rat cell-line N1-S1. We also employed a xenograft mouse model (HuH-7), a zebrafish model (JHH-6), and an orthotopic syngeneic rat model (N1-S1) of HCC. Results: 5-Aza downregulated cell viability/growth/migration/adhesion by upregulating miR-139-5p, which in turn downregulated ROCK2/cyclin D1/E2F1 and increased p27kip1, resulting in G1/G0 cell accumulation. Moreover, a decrease in cyclin B1 and an increase in p27kip1 led to G2/M accumulation. Finally, we observed a decrease in MMP-2 levels, a stimulator of HCC cell migration. Aza effects were confirmed in the mouse model; in the zebrafish model, we also demonstrated the downregulation of tumor neo-angiogenesis, and in the orthotopic rat model, we observed impaired N1-S1 grafting in a healthy liver. Conclusion: We demonstrate for the first time that 5-Aza can impair HCC development via upregulation of miR-139-5p, which in turn impairs the ROCK2/cyclin D1/E2F1/cyclin B1 pro-proliferative pathway and the ROCK2/MMP-2 pro-migratory pathway. Thus, we provide novel information about 5-Aza mechanisms of action and deepen the knowledge about the crosstalk among ROCK2/cyclin D1/E2F1/cyclin B1/p27kip1/MMP-2 in HCC.
- Published
- 2022
- Full Text
- View/download PDF